⚠️  DEMO SITE ONLY — FOR TESTING PURPOSES — This is a fictional demonstration for Adobe Universal Editor testing. Calvexa® and selvegepant are not real medicines. NovaPharm Inc. is a fictional company. Not affiliated with any real pharmaceutical product or company.  ⚠️
Important Safety Information
IMPORTANT SAFETY INFORMATION: Calvexa® (selvegepant) is contraindicated in patients with known hypersensitivity to selvegepant or any excipients. Most common adverse reactions (≥2%): nausea, indigestion, abdominal pain. Do not use in severe hepatic impairment. Please see full Prescribing Information.
#1 New Prescription in Its Class†

Treat & Help Prevent Migraine With One Medicine

For acute treatment, many patients experienced pain relief within 2 hours — in some patients lasting up to 48 hours.

†Based on prescription data as brand in class (oral CGRP receptor antagonists). Current as of 2025.

💊
Calvexa® ODT 75 mg
INDICATION: Calvexa® (selvegepant) is indicated for the acute treatment of migraine attacks with or without aura, and for the preventive treatment of episodic migraine, in adults.

Calvexa® helps treat migraine in 2 ways

1

Acute Treatment

Treat attacks when they happen

59.3%
Pain relief at 2 hours vs 43.3% with placebo
21.2%
Pain freedom at 2 hours vs 10.9% with placebo
35.1%
Freedom from most bothersome symptom at 2 hours vs 26.8%
Learn About Acute Treatment

Do not take more than 1 tablet in 24 hours.

2

Prevention

Reduce migraine days every month

4.3
Fewer monthly migraine days during weeks 9–12 vs 3.5 fewer with placebo
50%
Of patients achieved ≥50% reduction in monthly migraine days vs 26%
Every other
Day dosing — one tablet every other day for prevention
Learn About Prevention

Safety of more than 18 doses in a 30-day period has not been established.

Savings Card
as little as $0*
per prescription fill for eligible patients

  • Eligible commercially insured patients
  • No membership fees required
  • Download your card instantly
  • Use at participating pharmacies nationwide
Download Savings Card

Get Calvexa® for as little as $0*

We believe cost should never be a barrier to migraine relief. Eligible commercially insured patients can access Calvexa® with significant savings through our patient support program.

*Eligible commercially insured patients may pay as little as $0 per prescription. Insurance coverage must be approved. Not valid for Medicare/Medicaid patients. Maximum annual benefit applies.

Real patients. Real stories.

Individual results may vary. Patients were invited to share their experiences with Calvexa®.

👩‍🦱
Maria, 38
"I used to cancel plans all the time. Since starting Calvexa®, I've been able to show up for my family again."
👨‍💼
James, 45
"The dissolving tablet is so convenient. I always have it with me and it starts working fast."
👩‍🔬
Priya, 31
"My migraines were affecting my work. The prevention aspect of Calvexa® has changed everything for me."
View All Patient Stories

Important Safety Information

CONTRAINDICATIONS

Calvexa® (selvegepant) is contraindicated in patients with known hypersensitivity to selvegepant or to any of the excipients.

WARNINGS AND PRECAUTIONS

Discontinue Calvexa® if a serious hypersensitivity reaction occurs. Avoid use in patients with severe hepatic impairment.

ADVERSE REACTIONS

Most common adverse reactions (≥2% vs placebo): nausea (2.7%), indigestion (2.4%), abdominal pain (1.5%).

Please see full Prescribing Information, including Patient Information.

⚠️ DEMO SITE ONLY — FOR ADOBE UNIVERSAL EDITOR TESTING PURPOSES ⚠️
Calvexa® (selvegepant) is a fictional drug. NovaPharm Inc. is a fictional company. All clinical data shown is illustrative only and does not represent real medical data or real clinical trials. This site was created solely to demonstrate Adobe Universal Editor capabilities and is not affiliated with or endorsed by any pharmaceutical company or regulatory body.